SCHEMBL3608180

SCHEMBL3608180

O=C(Cn1ccc2cccc(-c3ccc(Cl)cc3)c21)NCCNCC1CCCCC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.45
TSHR P16473 2/20 0.45
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
NPY5R Q15761 1/20 0.41
KDM4E B2RXH2 4/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
EPHX2 P34913 2/20 0.39
EPHX1 P07099 1/20 0.39
CNR1 P21554 3/20 0.38
CNR2 P34972 3/20 0.38
HSD17B10 Q99714 2/20 0.38
ALDH1A1 P00352 1/20 0.38
MAPK1 P28482 1/20 0.38
CACNA1G O43497 1/20 0.37
MAPT P10636 1/20 0.36
LMNA P02545 2/20 0.35
TP53 P04637 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3597289 0.91 ALDH1A1 (0.41) HTTTSHRMEN1KMT2ANPY5R
SCHEMBL3608260 0.91 GRIN2B (0.42) HTTTSHRMEN1KMT2ANPY5R
SCHEMBL3594707 0.91 NPC1 (0.41) HTTTSHRKMT2ANPY5RKDM4E
SCHEMBL3589635 0.90 NPY5R (0.41) HTTTSHRMEN1KMT2ANPY5R
SCHEMBL3589653 0.89 ROCK2 (0.38) HTTTSHRMEN1KMT2ANPY5R
SCHEMBL3605921 0.88 EPHX2 (0.41) HTTMEN1KMT2ANPY5RKDM4E
SCHEMBL3605625 0.88 MGLL (0.38) HTTNPY5RKDM4EEPHX2HSD17B10
SCHEMBL3596540 0.86 HSD17B10 (0.37) HTTTSHRMEN1KMT2ANPY5R
SCHEMBL3605994 0.85 PIM1 (0.42) HTTMEN1KMT2ANPY5RKDM4E
SCHEMBL3592317 0.85 KDM4E (0.41) HTTTSHRNPY5RKDM4ERAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7807704-B2 Bicyclic, nitrogen-containing compounds modulating CXCR4 and/or CCXCKR2 CHEMOCENTRYX, INC. (US) 2010-10-05 US disclosed
US-20070275965-A1 CXCR4 modulators CHEMOCENTRYX, INC. (US) 2007-11-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070275965-A1 CXCR4 modulators CXCL12, CXCR4, CXCR1 HTT 1553/4885TSHR 1277/4885MEN1 4362/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.